![The risk of all-cause and cause-specific mortality in people prescribed mirtazapine: an active comparator cohort study using electronic health records | BMC Medicine | Full Text The risk of all-cause and cause-specific mortality in people prescribed mirtazapine: an active comparator cohort study using electronic health records | BMC Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12916-022-02247-x/MediaObjects/12916_2022_2247_Fig1_HTML.png)
The risk of all-cause and cause-specific mortality in people prescribed mirtazapine: an active comparator cohort study using electronic health records | BMC Medicine | Full Text
![These highlights do not include all the information needed to use MIRTAZAPINE TABLETS safely and effectively. See full prescribing information for MIRTAZAPINE TABLETS.MIRTAZAPINE tablets, for oral use Initial U.S. Approval: 1996 These highlights do not include all the information needed to use MIRTAZAPINE TABLETS safely and effectively. See full prescribing information for MIRTAZAPINE TABLETS.MIRTAZAPINE tablets, for oral use Initial U.S. Approval: 1996](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=Mirtazapine-03.jpg&id=616890)
These highlights do not include all the information needed to use MIRTAZAPINE TABLETS safely and effectively. See full prescribing information for MIRTAZAPINE TABLETS.MIRTAZAPINE tablets, for oral use Initial U.S. Approval: 1996
![Effects of CYP2D6 activity on the efficacy and safety of mirtazapine in patients with depressive disorders and comorbid alcohol use disorder Effects of CYP2D6 activity on the efficacy and safety of mirtazapine in patients with depressive disorders and comorbid alcohol use disorder](https://cdnsciencepub.com/cms/10.1139/cjpp-2019-0177/asset/images/cjpp-2019-0177tab3.gif)